MB
Mukesh Balwantrai Mehta
About Mukesh Balwantrai Mehta
Data last updated:
Mukesh Balwantrai Mehta has 39 years in corporate governance. Holds Director role. Currently with 1 company, including Super Alloys And Metals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Super Alloys And Metals Private Limited at ₹1.78 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Super Alloys And Metals Private Limited U32201GJ1981PTC004487 | Director | 21 Nov 1986 | 1981 | ₹1.78 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mukesh Balwantrai Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mukesh Balwantrai Mehta
Mukesh Balwantrai Mehta has 39 years in corporate governance. Holds Director role. Currently with 1 company, including Super Alloys And Metals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Super Alloys And Metals Private Limited at ₹1.78 Cr (FY 2025).
Mukesh Balwantrai Mehta is associated with 1 company as Director, including Super Alloys And Metals Private Limited (₹1.78 Cr).
Mukesh Balwantrai Mehta has expertise in General Business.
Mukesh Balwantrai Mehta has 39 years in corporate governance.
By reported revenue, the largest current company of Mukesh Balwantrai Mehta is Super Alloys And Metals Private Limited, with revenue of ₹1.78 Cr (FY 2025).
Mukesh Balwantrai Mehta currently holds positions at 1 company: Super Alloys And Metals Private Limited (₹1.78 Cr).